194 related articles for article (PubMed ID: 26672783)
1. Prognosis: Proportionate response.
DeWeerdt S
Nature; 2015 Dec; 528(7582):S124-5. PubMed ID: 26672783
[No Abstract] [Full Text] [Related]
2. The dilemma of prostate-specific antigen testing.
Leach R; Thompson IM
Arch Intern Med; 2012 Jun; 172(11):835-6. PubMed ID: 22905350
[No Abstract] [Full Text] [Related]
3. Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countries.
Okihara K; Ochiai A; Kamoi K; Fujizuka Y; Miki T; Ito K
Int J Urol; 2015 Apr; 22(4):334-41. PubMed ID: 25827049
[TBL] [Abstract][Full Text] [Related]
4. New tests for prostate cancer may be nearing the clinic.
Tuma RS
J Natl Cancer Inst; 2010 Jun; 102(11):752-4. PubMed ID: 20498428
[No Abstract] [Full Text] [Related]
5. Re: urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the canary prostate active surveillance study.
Taneja SS
J Urol; 2014 Jan; 191(1):75-6. PubMed ID: 24331481
[No Abstract] [Full Text] [Related]
6. Re: Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.
Taneja SS
J Urol; 2013 Nov; 190(5):1764. PubMed ID: 24120780
[No Abstract] [Full Text] [Related]
7. New tests for prostate cancer.
O'Hanlon LH
J Natl Cancer Inst; 2013 Nov; 105(22):1672-4. PubMed ID: 24198330
[No Abstract] [Full Text] [Related]
8. Current status of prostate cancer management in the prostate-specific antigen era.
Sartor O
Clin Prostate Cancer; 2004 Mar; 2(4):200-1. PubMed ID: 15072599
[No Abstract] [Full Text] [Related]
9. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer.
Nilsson J; Skog J; Nordstrand A; Baranov V; Mincheva-Nilsson L; Breakefield XO; Widmark A
Br J Cancer; 2009 May; 100(10):1603-7. PubMed ID: 19401683
[TBL] [Abstract][Full Text] [Related]
10. Prognostic accuracy of prostate health index and urinary prostate cancer antigen 3 in predicting pathologic features after radical prostatectomy.
Vlaeminck-Guillem V
Urol Oncol; 2015 Nov; 33(11):498. PubMed ID: 26116413
[No Abstract] [Full Text] [Related]
11. [Contemporary markers and histological features of prostate cancer].
Vasilyev AO; Prilepskaya EA; Kovylina MV; Govorov AV; Sadchenko AV; Sidorenkov AV; Pushkar DY
Urologiia; 2016 Dec; (6):164-166. PubMed ID: 28248064
[TBL] [Abstract][Full Text] [Related]
12. Molecular biomarkers to guide precision medicine in localized prostate cancer.
Smits M; Mehra N; Sedelaar M; Gerritsen W; Schalken JA
Expert Rev Mol Diagn; 2017 Aug; 17(8):791-804. PubMed ID: 28635333
[TBL] [Abstract][Full Text] [Related]
13. Urinary Biomarkers for Prostate Cancer.
Tosoian JJ; Ross AE; Sokoll LJ; Partin AW; Pavlovich CP
Urol Clin North Am; 2016 Feb; 43(1):17-38. PubMed ID: 26614026
[TBL] [Abstract][Full Text] [Related]
14. Seminal fluid: a useful source of prostate cancer biomarkers?
Roberts MJ; Richards RS; Gardiner RA; Selth LA
Biomark Med; 2015; 9(2):77-80. PubMed ID: 25689895
[No Abstract] [Full Text] [Related]
15. Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population.
Wei HM; Chen HT; Wang P; Wu YS; Na R; Liu F; Sun JS; Jiang DK; Lu DR; Xu J
Asian J Androl; 2015; 17(1):168-70. PubMed ID: 25412674
[No Abstract] [Full Text] [Related]
16. Interpretation of the prostate cancer gene 3 in reference to the individual clinical background: implications for daily practice.
Schilling D; Hennenlotter J; Munz M; Bökeler U; Sievert KD; Stenzl A
Urol Int; 2010; 85(2):159-65. PubMed ID: 20424427
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification of prostate cancer 2016.
Reiter RE
Scand J Clin Lab Invest Suppl; 2016; 245():S54-9. PubMed ID: 27533326
[TBL] [Abstract][Full Text] [Related]
18. Urine markers in monitoring for prostate cancer.
Jamaspishvili T; Kral M; Khomeriki I; Student V; Kolar Z; Bouchal J
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):12-9. PubMed ID: 19652665
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
Salagierski M; Schalken JA
J Urol; 2012 Mar; 187(3):795-801. PubMed ID: 22245323
[TBL] [Abstract][Full Text] [Related]
20. Screening for prostate cancer.
Neal DE; Donovan JL
Ann Oncol; 1998 Dec; 9(12):1289-92. PubMed ID: 9932157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
